To access this element change to forms mode OFF
Grant Award View - GA52650
Personalising treatment and surveillance for colorectal cancer:...
GA ID:
GA52650
Agency:
Cancer Australia
Approval Date:
10-Apr-2019
Publish Date:
2-Jul-2019
Category:
Cancer
Grant Term:
1-Jun-2019 to 31-May-2022
Value (AUD):
$553,196.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
CA 18/19 Improved cancer control
Grant Program:
2018 Priority-driven Collaborative Cancer Research Scheme
Grant Activity:
Personalising treatment and surveillance for colorectal cancer: prognostication with the circulating tumour-derived methylated DNA markers BCAT1 and IKZF1
Purpose:
Bowel cancer is one of the most common cancers in Australia. Despite surgery, approximately one third of patients will have the cancer return within 3 years. The Investigators have developed a blood test that can detect bowel cancer and will now determine if it can also be used to determine which patients are at higher risk for cancer recurrence. This would allow specialists to focus therapies, especially chemotherapy, on those who will benefit most and avoid it in those who do not need it.
GO ID:
GO Title:
2018 PdCCRS Project Grants for funding commencing 2019
Internal Reference ID:
2018 PdCCRS
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
The Flinders University of South Australia
Recipient ABN:
65 542 596 200
Grant Recipient Location
Suburb:
Bedford Park
Town/City:
Adelaide
Postcode:
5042
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
National
Postcode:
Multiple
Country:
AUSTRALIA